Ming Yan - Mar 11, 2024 Form 4 Insider Report for Cytek Biosciences, Inc. (CTKB)

Role
CHIEF TECHNOLOGY OFFICER, Director
Signature
/s/ Valerie Barnett, Attorney-in-Fact
Stock symbol
CTKB
Transactions as of
Mar 11, 2024
Transactions value $
-$21,017
Form type
4
Date filed
3/13/2024, 06:55 PM
Previous filing
Mar 8, 2024
Next filing
Mar 19, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTKB Common Stock Options Exercise +9.82K +0.16% 6.05M Mar 11, 2024 Direct F1
transaction CTKB Common Stock Tax liability -$21K -2.91K -0.05% $7.22 6.05M Mar 11, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTKB Restricted Stock Units Options Exercise $0 -9.82K -10% $0.00 88.4K Mar 11, 2024 Common Stock 9.82K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock.
F2 Represents the number of shares withheld by and surrendered to the Issuer on March 11, 2024, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award.
F3 The shares subject to the RSU Award shall vest over four years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2023 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2023 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2023 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting each March 10, 2024 and each March 10 thereafter, until fully vested.